All Insights
What's in a name? Help your medicine go down well with consumers and regulators
The choice of the right brand name for a medicine or pharmaceutical product is essential for establishing a lasting market
Quantum computing | Ground-breaking commercial opportunities from solving the (as yet) unsolvable
Quantum computers will support powerful commercial applications by solving currently intractable problems. We consider the pathway to bringing this technology
Life sciences companies turn to public markets for injections of capital
London markets have remained open during the pandemic allowing for a surge in life sciences and healthcare sector deals including
Ethics and Compliance | New ethical controls coming for interactions with healthcare professionals in France
New rules coming into force on 1 October 2020 will give professional associations the power to block contracts or hospitality
A shot in the arm for generics as UK courts refuse injunction to prevent potential patent infringement
In an unusual decision for life sciences patent disputes, the UK courts refused to restrain a generic drug manufacturer from
UK Supreme Court upholds appeal by biotech firm Kymab to revoke antibody patents held by US giant Regeneron
Judgment overturns the Court of Appeal's decision on ground-breaking technology, rebalances the legal equilibrium on sufficiency, and grants reprieve to
Coronavirus Legal Briefing | The activist state
Welcome to Osborne Clarke's Coronavirus Legal Briefing, our newsletter on business law issues in these sombre times. In this edition
Government guidance on responsible contractual behaviour
Overview and analysis of the new guidance from The Cabinet Office and the Infrastructure and Projects Authority
